
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 7-(4-(2-(6-(3-(4-(2-(2-(4-(3-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-((hydroxy(hydroxy(phosphonooxy)phosphoryloxy)phosphoryloxy)methyl)tetrahydrofuran-2-yl)-2-oxo-2,3-dihydropyrimidin-4(1H)-ylideneaminooxy)propyl)phenoxy)acetamido)ethyl)-1H-1,2,3-triazol-1-yl)propylamino)-6-oxohexylamino)-2-oxoethoxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide's neighborhood in the knowledge graph.

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for 7-(4-(2-(6-(3-(4-(2-(2-(4-(3-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-((hydroxy(hydroxy(phosphonooxy)phosphoryloxy)phosphoryloxy)methyl)tetrahydrofuran-2-yl)-2-oxo-2,3-dihydropyrimidin-4(1H)-ylideneaminooxy)propyl)phenoxy)acetamido)ethyl)-1H-1,2,3-triazol-1-yl)propylamino)-6-oxohexylamino)-2-oxoethoxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide.

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with 7-(4-(2-(6-(3-(4-(2-(2-(4-(3-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-((hydroxy(hydroxy(phosphonooxy)phosphoryloxy)phosphoryloxy)methyl)tetrahydrofuran-2-yl)-2-oxo-2,3-dihydropyrimidin-4(1H)-ylideneaminooxy)propyl)phenoxy)acetamido)ethyl)-1H-1,2,3-triazol-1-yl)propylamino)-6-oxohexylamino)-2-oxoethoxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide.
7-(4-(2-(6-(3-(4-(2-(2-(4-(3-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-((hydroxy(hydroxy(phosphonooxy)phosphoryloxy)phosphoryloxy)methyl)tetrahydrofuran-2-yl)-2-oxo-2,3-dihydropyrimidin-4(1H)-ylideneaminooxy)propyl)phenoxy)acetamido)ethyl)-1H-1,2,3-triazol-1-yl)propylamino)-6-oxohexylamino)-2-oxoethoxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide bioactivity P2Y purinoceptor 6
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
7-(4-(2-(6-(3-(4-(2-(2-(4-(3-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-((hydroxy(hydroxy(phosphonooxy)phosphoryloxy)phosphoryloxy)methyl)tetrahydrofuran-2-yl)-2-oxo-2,3-dihydropyrimidin-4(1H)-ylideneaminooxy)propyl)phenoxy)acetamido)ethyl)-1H-1,2,3-triazol-1-yl)propylamino)-6-oxohexylamino)-2-oxoethoxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide bioactivity P2Y purinoceptor 2
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG
7-(4-(2-(6-(3-(4-(2-(2-(4-(3-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-((hydroxy(hydroxy(phosphonooxy)phosphoryloxy)phosphoryloxy)methyl)tetrahydrofuran-2-yl)-2-oxo-2,3-dihydropyrimidin-4(1H)-ylideneaminooxy)propyl)phenoxy)acetamido)ethyl)-1H-1,2,3-triazol-1-yl)propylamino)-6-oxohexylamino)-2-oxoethoxy)styryl)-5,5-difluoro-3-(thiophen-2-yl)-5H-dipyrrolo[1,2-c:1',2'-f][1,3,2]diazaborinin-4-ium-5-uide bioactivity P2Y purinoceptor 4
Knowledge Graph Assertion (Entity type)A Knowledge Graph Assertion from IDG